Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michele Baccarani Giovanni Martinelli Philipp le Coutre Jorge Eduardo Cortes Elisabetta Abruzzese Jerald P Radich Norbert Gattermann Oliver Ottmann Kazimierz Kuliczkowski Hagop Kantarjian Jane F Apperley Yaping Shou Richard A. Larson Giuseppe Saglio Andreas Hochhaus Francis Giles Francois-Xavier Mahon |
| Publication date | November 29, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |